Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantin Lapa

Showing results (241-250 of 269) with videos related to

Pageof 27
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 26, 2020
CXCR4-Targeted PET Imaging of Central Nervous System B-Cell LymphomaPeter Herhaus, Jana Lipkova, Felicitas Lammer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone LymphomaJohannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2015
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary DiseaseKen Herrmann, Margret Schottelius, Constantin Lapa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PETAndreas K Buck, Alexander Haug, Niklas Dreher, et al.
Thyroid : Official Journal of the American Thyroid Association|August 18, 2021
Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid CancerViktoria Florentine Koehler, Elke Berg, Pia Adam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2025
Multicentric Matched-Pair Analysis of Long-Term Hematotoxicity of Peptide Receptor Radionuclide Therapy in Patients PostsplenectomyLisa Steinhelfer, Friederike Jungmann, Lukas Endroes, et al.
Theranostics|January 2, 2018
Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed TheranosticsStefan Habringer, Constantin Lapa, Peter Herhaus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Initial Clinical Experience with [<sup>177</sup>Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and DosimetryLisa Glantschnig, Johanna S Enke, Bradley W Schuller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2026
Effects of androgen receptor signaling inhibitors on absorbed doses in mCRPC patients undergoing [<sup>177</sup>Lu]Lu-PSMA-617 or [<sup>177</sup>Lu]Lu-PSMA-I&T therapy: dosimetry resultsJosef Zahner, Astrid Delker, Zachary Ells, et al.
Theranostics|August 2, 2019
Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?Leo Rasche, Manoj Kumar, Grant Gershner, et al.
Pageof 27

Showing results (241-250 of 269) with videos related to

Sort By:
Pageof 27
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 26, 2020
CXCR4-Targeted PET Imaging of Central Nervous System B-Cell LymphomaPeter Herhaus, Jana Lipkova, Felicitas Lammer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone LymphomaJohannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2015
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary DiseaseKen Herrmann, Margret Schottelius, Constantin Lapa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PETAndreas K Buck, Alexander Haug, Niklas Dreher, et al.
Thyroid : Official Journal of the American Thyroid Association|August 18, 2021
Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid CancerViktoria Florentine Koehler, Elke Berg, Pia Adam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2025
Multicentric Matched-Pair Analysis of Long-Term Hematotoxicity of Peptide Receptor Radionuclide Therapy in Patients PostsplenectomyLisa Steinhelfer, Friederike Jungmann, Lukas Endroes, et al.
Theranostics|January 2, 2018
Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed TheranosticsStefan Habringer, Constantin Lapa, Peter Herhaus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Initial Clinical Experience with [<sup>177</sup>Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and DosimetryLisa Glantschnig, Johanna S Enke, Bradley W Schuller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2026
Effects of androgen receptor signaling inhibitors on absorbed doses in mCRPC patients undergoing [<sup>177</sup>Lu]Lu-PSMA-617 or [<sup>177</sup>Lu]Lu-PSMA-I&T therapy: dosimetry resultsJosef Zahner, Astrid Delker, Zachary Ells, et al.
Theranostics|August 2, 2019
Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?Leo Rasche, Manoj Kumar, Grant Gershner, et al.
Pageof 27